相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Emerging Role of PIWI-Interacting RNAs (piRNAs) in Gastrointestinal Cancers: An Updated Perspective
Ismael Riquelme et al.
CANCERS (2022)
Long Non-Coding LEF1-AS1 Sponge miR-5100 Regulates Apoptosis and Autophagy in Gastric Cancer Cells via the miR-5100/DEK/AMPK-mTOR Axis
Huimin Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Abnormally Expressed lncRNAs as Potential Biomarkers for Gastric Cancer Risk: A Diagnostic Meta-Bioinformatics Analysis
Ying-ying Dong et al.
BIOMED RESEARCH INTERNATIONAL (2022)
lncRNA HIT000218960 enhances resistance to 5-fluorouracil by promoting HMGA2 and activating the AKT/mTOR/P70S6K pathway in gastric cancer cells
Li Bai et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2022)
FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway
Qiong Wu et al.
MOLECULAR ONCOLOGY (2021)
Long noncoding RNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway
Yu Hu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Gene regulation by long non-coding RNAs and its biological functions
Luisa Statello et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
lncRNA OGFRP1 promotes tumor progression by activating the AKT/mTOR pathway in human gastric cancer
Jingzhou Zhang et al.
Aging-US (2021)
CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma
Qianmei Fu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
LncRNA MALAT1 promotes gastric cancer progression via inhibiting autophagic flux and inducing fibroblast activation
Zhenqiang Wang et al.
CELL DEATH & DISEASE (2021)
Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer
Chao Dong et al.
FRONTIERS IN PHARMACOLOGY (2021)
The ever-increasing importance of cancer as a leading cause of premature death worldwide
Freddie Bray et al.
CANCER (2021)
Noncoding RNA therapeutics - challenges and potential solutions
Melanie Winkle et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
HDAC3-mediated lncRNA-LOC101928316 contributes to cisplatin resistance in gastric cancer via activating the PI3K-Akt-mTOR pathway
Hengjie Ren et al.
NEOPLASMA (2021)
Long Noncoding RNA LIT3527 Knockdown induces Apoptosis and Autophagy through inhibiting mTOR pathway in Gastric Cancer Cells
Boya Wang et al.
JOURNAL OF CANCER (2021)
Long noncoding RNAs in cancer metastasis
S. John Liu et al.
NATURE REVIEWS CANCER (2021)
Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines
Barbara Mora-Lagos et al.
PLOS ONE (2020)
Silencing of Long Non-Coding RNA Colon Cancer-Associated Transcript 2 Inhibits the Growth and Metastasis of Gastric Cancer Through Blocking mTOR Signaling
Sen Lin et al.
ONCOTARGETS AND THERAPY (2020)
LncRNA AC093818.1 accelerates gastric cancer metastasis by epigenetically promoting PDK1 expression
Ming-chen Ba et al.
CELL DEATH & DISEASE (2020)
Long non-coding RNAs regulate drug resistance in cancer
Kaisheng Liu et al.
MOLECULAR CANCER (2020)
Gastric cancer: a comprehensive review of current and future treatment strategies
Rachel E. Sexton et al.
CANCER AND METASTASIS REVIEWS (2020)
PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond
Sadegh Fattahi et al.
LIFE SCIENCES (2020)
The lncRNA Toolkit: Databases and In Silico Tools for lncRNA Analysis
Holly R. Pinkney et al.
NON-CODING RNA (2020)
The functional role of long noncoding RNA in resistance to anticancer treatment
Yidi Qu et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Overexpression of long noncoding RNA GAS5 suppresses tumorigenesis and development of gastric cancer by sponging miR-106a-5p through the Akt/mTOR pathway
Shuaijun Dong et al.
BIOLOGY OPEN (2019)
LncRNA-LOC101928316 contributes to gastric cancer progression through regulating PI3K-Akt-mTOR signaling pathway
Chengyun Li et al.
CANCER MEDICINE (2019)
Establishing a correlation between RIN and A260/280 along with the multivariate evaluation of factors affecting the quality of RNA in cryopreserved cancer bio-specimen
Sanket G. Shah et al.
CELL AND TISSUE BANKING (2019)
mTOR: Role in cancer, metastasis and drug resistance
Avaniyapuram Kannan Murugan
SEMINARS IN CANCER BIOLOGY (2019)
Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics
Baitang Ning et al.
BIOCHEMICAL PHARMACOLOGY (2019)
The Role of Non-coding RNAs in Oncology
Frank J. Slack et al.
CELL (2019)
LncRNA NORAD Promotes Proliferation And Inhibits Apoptosis Of Gastric Cancer By Regulating miR-214/Akt/mTOR Axis
Wei Tao et al.
ONCOTARGETS AND THERAPY (2019)
The Down-Regulation of lncRNA PCAT18 Promotes the Progression of Gastric Cancer via MiR-107/PTEN/PI3K/AKT Signaling Pathway
Ping Chen et al.
ONCOTARGETS AND THERAPY (2019)
STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy
Jin-Fei Chen et al.
MOLECULAR CANCER (2018)
Platforms for Investigating LncRNA Functions
John Lalith Charles Richard et al.
SLAS TECHNOLOGY (2018)
Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway
Lisi Zeng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Defining the purity of exosomes required for diagnostic profiling of small RNA suitable for biomarker discovery
Camelia Quek et al.
RNA BIOLOGY (2017)
Overcoming cellular barriers for RNA therapeutics
Steven F. Dowdy
NATURE BIOTECHNOLOGY (2017)
Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway
Chengyun Li et al.
ONCOTARGET (2017)
Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA
Iain M. Dykes et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2017)
The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway
Yanhua Li et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Behzad Mansoori et al.
ADVANCED PHARMACEUTICAL BULLETIN (2017)
STRUCTURAL BIOLOGY Architecture of human mTOR complex 1
Christopher H. S. Aylett et al.
SCIENCE (2016)
miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway
Ismael Riquelme et al.
CELLULAR ONCOLOGY (2016)
4E-BP1, a multifactor regulated multifunctional protein
Xiaoyu Qin et al.
CELL CYCLE (2016)
Structural insights of mTOR complex 1
Hai-Xin Yuan et al.
CELL RESEARCH (2016)
The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines
Ismael Riquelme et al.
PATHOLOGY & ONCOLOGY RESEARCH (2016)
Long non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasis
Q. Xu et al.
CELL DEATH & DISEASE (2016)
Molecular mechanisms of chemoresistance in gastric cancer
Wen-Jia Shi et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer
Ismael Riquelme et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance
Xian-wen Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
The emerging role of IncRNAs in cancer
Maite Huarte
NATURE MEDICINE (2015)
Regulation of mTORC1 by PI3K signaling
Christian C. Dibble et al.
TRENDS IN CELL BIOLOGY (2015)
Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice
Helga Weber et al.
ONCOTARGET (2015)
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
Ismael Riquelme et al.
ONCOTARGET (2015)
PI3K/AKT signaling pathway and cancer: an updated review
Miriam Martini et al.
ANNALS OF MEDICINE (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
Jiri Polivka et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Transcriptional regulatory functions of nuclear long noncoding RNAs
Keith W. Vance et al.
TRENDS IN GENETICS (2014)
The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance
Oscar Tapia et al.
VIRCHOWS ARCHIV (2014)
Potential role of metabolomics in diagnosis and surveillance of gastric cancer
Angela W. Chan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Gastric cancer: Prevention, screening and early diagnosis
Victor Pasechnikov et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways
L. Chang et al.
CELL DEATH & DISEASE (2014)
Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a
Er-bao Zhang et al.
ONCOTARGET (2014)
Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood
Lesley Cheng et al.
JOURNAL OF EXTRACELLULAR VESICLES (2014)
The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere
Jing Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma
Hai Yan Yang et al.
MOLECULAR MEDICINE REPORTS (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma
Fernando Rivera et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Shile Huang et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2012)
Role of p70S6K1-mediated Phosphorylation of eIF4B and PDCD4 Proteins in the Regulation of Protein Synthesis
Michael D. Dennis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Sonic Hedgehog Pathway Promotes Metastasis and Lymphangiogenesis via Activation of Akt, EMT, and MMP-9 Pathway in Gastric Cancer
Young A. Yoo et al.
CANCER RESEARCH (2011)
Body fluid derived exosomes as a novel template for clinical diagnostics
Sascha Keller et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony
Kathryn G. Foster et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A comprehensive map of the mTOR signaling network
Etienne Caron et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
Gastric cancer
Vincenzo Catalano et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2009)
The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray
Li Xiao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
Mitchell Guttman et al.
NATURE (2009)
The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications
Alexandre Arcaro et al.
CURRENT GENOMICS (2007)
Protein expression profiling and molecular classification of gastric cancer by the tissue array method
Hye Seung Lee et al.
CLINICAL CANCER RESEARCH (2007)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Perturbations of the AKT signaling pathway in human cancer
DA Altomare et al.
ONCOGENE (2005)
PI3K/Akt signalling pathway and cancer
JAF Vara et al.
CANCER TREATMENT REVIEWS (2004)